Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on May 30, 2026

May 30, 2026

Momcozy สร้างความเชื่อมั่นก่อนตัดสินใจซื้อในกลุ่มคุณแม่เอเชียตะวันออกเฉียงใต้ ต้อนรับแคมเปญ 6.6

Indeterminate EIN Presswire

May 30, 2026

Momcozy Perkuat Kepercayaan Ibu Asia Tenggara Sebelum Berbelanja di Momen 6.6

Indeterminate EIN Presswire

May 30, 2026

Momcozy កំពុងកសាងទំនុកចិត្តមុនពេលទិញក្នុងចំណោមម្ដាយអាស៊ីអាគ្នេយ៍ មុនយុទ្ធនាការ 6.6

Indeterminate EIN Presswire

May 30, 2026

Beyond the Cart: How Momcozy is Securing 'Pre-Checkout Trust' Among Southeast Asian Mothers Ahead of 6.6

Indeterminate EIN Presswire

May 30, 2026

Beyond the Cart: How Momcozy is Securing 'Pre-Checkout Trust' Among Southeast Asian Mothers Ahead of 6.6

Indeterminate EIN Presswire

May 30, 2026

Beyond the Cart: How Momcozy is Securing 'Pre-Checkout Trust' Among Southeast Asian Mothers Ahead of 6.6

Indeterminate EIN Presswire

May 30, 2026

Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours

Indeterminate GlobeNewswire

May 30, 2026

Orion Pharma julkisti ensimmäiset tulokset Faasi 1/2 TEADES-tutkimuksesta ODM-212-molekyylillä (TEAD-estäjä) potilailla, joilla on kiinteitä kasvaimia ja edennyt syöpä

Indeterminate GlobeNewswire

May 30, 2026

Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology

Indeterminate GlobeNewswire

May 30, 2026

Globale Daten der ROSETTA Lung-02-Studie: Ermutigende Wirksamkeit für BioNTechs und Bristol Myers Squibbs bispezifischen PD-L1xVEGF-A-Immunmodulator-Kandidat Pumitamig bei nicht-kleinzelligem Lungenkrebs

Indeterminate GlobeNewswire

May 30, 2026

Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

Indeterminate GlobeNewswire

May 30, 2026

ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026

Indeterminate GlobeNewswire

May 30, 2026

Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)

Indeterminate GlobeNewswire

May 30, 2026

Vapofil Reviews [URGENT REPORT 2026] The Shocking VapoFil Male Enhancement Supplement Trend Everyone Is Talking About

Indeterminate GlobeNewswire

May 30, 2026

ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

Indeterminate GlobeNewswire

May 30, 2026

World Vape Day 2026: One Switch – Everyone Wins

Indeterminate GlobeNewswire

May 30, 2026

Día Mundial del Vapeo 2026: Un cambio: todos ganan

Indeterminate GlobeNewswire

May 30, 2026

Hari Vape Sedunia 2026: Satu Peralihan – Kemenangan untuk Semua

Indeterminate GlobeNewswire

May 30, 2026

Dia Mundial do Vape 2026: Uma Mudança, Todos Ganham

Indeterminate GlobeNewswire

May 30, 2026

JELLY TIDE [URGENT REPORT 2026]: The Shocking Rise of JellyTide Gummies—What Consumers Need to Know About the Viral Wellness Trend

Indeterminate GlobeNewswire